{
event: "article_read",
name: `Meet Sanofi MS Specialists`,
author: ``,
tags: `Multiple Sclerosis`,
publication_date: ``,
interaction_type: "content"
}
Read article
Meet Sanofi MS Specialists
Related articles
Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity
MAT-BH-2200369-V1-April/2022